SCHEMBL31069735

SCHEMBL31069735

Nc1nc2cc(-c3cnc4c(c3)C(=O)N(Cc3cc(OC(F)(F)F)ccc3F)CCS4(=O)=O)ccn2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 3/20 0.40
SCN1A P35498 1/20 0.36
SCN4A P35499 1/20 0.36
KCNH2 Q12809 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN9A Q15858 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
SCN8A Q9UQD0 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
PIK3CG P48736 7/20 0.35
PIK3CD O00329 6/20 0.35
CHRM1 P11229 2/20 0.33
KCNN4 O15554 1/20 0.33
RIPK1 Q13546 4/20 0.32
CHRM5 P08912 1/20 0.32
PAK4 O96013 1/20 0.32
JAK1 P23458 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25380687 1.00 TNIK (0.40) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL23761157 0.87 TNIK (0.41) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL31069722 0.85 TNIK (0.41) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL31069733 0.85 TNIK (0.48) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL31069734 0.85 TNIK (0.40) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25379735 0.85 TNIK (0.48) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25380728 0.85 TNIK (0.40) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25380390 0.85 TNIK (0.41) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL25380642 0.85 TNIK (0.39) TNIKSCN1ASCN4AKCNH2SCN5A
SCHEMBL31069732 0.85 TNIK (0.39) TNIKSCN1ASCN4AKCNH2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118556044-A Fused heterocyclic compound, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-08-27 CN disclosed